Central nervous system-acting agents and the treatment of erectile and sexual dysfunction

Current Urology Reports

Volumn 8, Issue 6, 2007, Pages 472-476

  Carson III, Culley C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; MELANOTAN II; N ACETYLNORLEUCYLASPARTYLHISTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHYLLYSINE 2,7 CYCLIC AMIDE; OXYTOCIN; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN; SILDENAFIL; TRAZODONE; UNCLASSIFIED DRUG;

BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIZZINESS; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; MEDIAL PREOPTIC AREA; NAUSEA; NONHUMAN; PENIS ERECTION; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; SYNCOPE; THALAMUS MIDLINE NUCLEUS; UNSPECIFIED SIDE EFFECT; VOMITING; YAWNING;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CLINICAL TRIALS AS TOPIC; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME;

EID: 36348944580     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0051-3     Document Type: Review

References (38)

1. Martin WJ, MacIntyre DE: Melanocortin receptors and erectile function. Eur Urol 2004, 45:706-713. Excellent review of the clinical and basic science data associated with sexual function and the melanocortin system.
2. McKenna KE. Central control of penile erection: Int J Impot Res 1998, 10:S25-S34.
3. Devidze N, Lee AW, Zhou J, Pfaff DW: CNS arousal mechanisms bearing on sex and other biologically regulated behaviors. Physiol Behav 2006, 88:283-293.
4. Giuliano F, Rampin O: Central neural regulation of penile erection. Neurosci Biobehav Rev, 24:517-533.
5. Giraldi A, Marson L, Nappi R, et al.: Physiology of female sexual function: animal models. J Sex Med 2004, 1:237-253.
6. Argiolas A, Melis MR. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog Neurobiol 2005, 76:1-21.
7. King SH, Mayorov AV, Balse-Srinivasan P, et al.: Melanocortin receptors, melanotropic peptides, and penile erection. Curr Top Med Chem 2007, 7:1111-1119.
8. Kiss A, Mikkelsen JD: Oxytocin - anatomy and functional assignments: a minireview. Endocr Regul 2005, 39:97-105.
9. Pfaus JG, Kippin TE, Coria-Avila G: What can animal models tell us about human sexual response? Annu Rev Sex Res 2003, 14:1-63.
10. Paredes RG, Agmo A: Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 2004, 73:179-226.
11. Hull EM, Muschamp JW, Sato S: Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 2004, 83:291-307.
12. Giuliano F, Allard J: Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug. Int J Impot Res 2002, 14:S53-S556.
13. Heaton JP. Key issues from the clinical trials of apomorphine SL. World J Urol 2001, 19:25-31.
14. Dula E, Bukofzer S, Perdok R, George M: Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol 2001, 39:558-553; discussion 564.
15. Mulhall JP, Bukofzer S, Edmonds AL, George M: An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction. Clin Ther 2001, 23:1260-1271.
16. Von Keitz AT, Stroberg P, Bukofzer S, et al.: A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction. BJU Int 2002, 89:409-415.
17. Porst H, Behre HM, Jungwirth A, Burkart M: Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction - an open, randomized cross-over study with flexible dosing. Eur J Med Res 2007, 12:61-67.
18. Eardley I, Wright P, MacDonagh R, et al.: An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction. BJU Int 2004, 93:1271-1275. Controlled trial of PDE5 inhibitor sildenafil in comparison with CNS stimulant apomorphine in clinical treatment of ED in a real-world setting.
19. Wessells H, Fuciarelli K, Hansen J, et al.: Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol 1998, 160:389-393.
20. Wessells H, Hruby VJ, Hackett J, et al.: Ac-Nle-c[Asp-His-DPhe-Arg- Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors. Neuroscience 2003, 118:755-762.
21. Shadiack AM, Sharma SD, Earle DC, et al.: Melanocortins in the treatment of male and female sexual dysfunction. Curr Top Med Chem 2007, 7:1137-1144. Best and most up-to-date review of the melanocortins and clinical and laboratory evidence for their effectiveness in the treatment of sexual dysfunction.
22. Diamond LE, Earle DC, Rosen RC, et al.: Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res 2004, 16:51-59.
23. Rosen RC, Diamond LE, Earle DC, et al.: Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res 2004, 16:135-142. Trial of CNS agent bremelanotide in men poorly responsive to sildenafil. Responses suggest place for this agent in the treatment of severe ED and as a supplement for PDE5 inhibitor failure.
24. Giuliano F: Control of penile erection by the melanocortinergic system: experimental evidences and therapeutic perspectives. J Androl 2004, 25:683-691.
25. Born J, Lange T, Kern W, et al.: Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002, 5:514-516.
26. Wessells H, Hruby VJ, Hackett J, et al.: MT-II induces penile erection via brain and spinal mechanisms. Ann N Y Acad Sci 2003, 994:90-95.
27. Diamond LE, Earle DC, Garcia WD, Spana C: Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology 2005, 65:755-759.
28. Diamond LE, Earle DC, Heiman JR, et al.: An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. J Sex Med 2006, 3:628-638. First reported trial of the effect of the CNS agent bremelanotide and sexual dysfunction in women. Suggests a place for these agents in the treatment of FSD.
29. Thackare H, Nicholson HD, Whittington K: Oxytocin - its role in male reproduction and new potential therapeutic uses. Hum Reprod Update 2006, 12:437-448.
30. Succu S, Sanna F, Melis T, et al.: Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: involvement of central oxytocin. Neuropharmacology 2007, 52:1034-1043.
31. Pedersen CA, Boccia ML: Vasopressin interactions with oxytocin in the control of female sexual behavior. Neuroscience 2006, 139:843-851.
32. Carson CC 3rd, Mino RD: Priapism associated with trazodone therapy. J Urol 1988, 139:369-370.
33. Meinhardt W, Schmitz PI, Kropman RF, et al.: Trazodone, a double blind trial for treatment of erectile dysfunction. Int J Impot Res 1997, 9:163-165.
34. Lee JJ, Hahm ET, Lee CH, Cho YW: Serotonergic modulation of GABAergic and glutamatergic synaptic transmission in mechanically isolated rat medial preoptic area neurons. Neuropsychopharmacology 2007, Mar 28 [Epub ahead of print].
35. Hull EM, Dominguez JM: Sexual behavior in male rodents. Horm Behav 2007, 52:45-55.
36. Song Y, Rajasekaran M: Characterization of hippocampal glutamate receptor subtypes in the central regulation of penile erection. J Urol 2004, (Suppl 380) [abstract 1442(171)].
37. Melis MR, Succu S, Spano MS, et al.: EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats. Eur J Pharmacol 2000, 404:137-143.
38. Rampin O, Monnerie R, Jerome N, et al.: Spinal control of erection by glutamate in rats. Am J Physiol Regul Integr Comp Physiol 2004, 286:710-718.